Lotus Eye Hospital and Institute share news, announcements and annual reports
NSE: LOTUSEYEBSE: 532998Healthcare ServicesSmall Cap
Lotus Eye Hospital and Institute Limited · Formerly Lotus Eye Care Hospital · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2008
Last close ₹109.15down ₹0.85 (0.77%)BSE ₹106.50
Share price at the NSE close on 30 Oct 2026. Previous close ₹110.00.
30 Oct: open ₹110.01, high ₹110.01, low ₹108.10
52-week range of traded prices to 30 Oct 2026
₹97.59Low, 30 Mar 2026₹147.00High, 30 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹227 Cr2,287th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 1,520.37
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.77
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 17,74995.6% delivered
Lotus Eye Hospital and Institute share news and announcements
455 announcements, routine notices left out, newest first. Page 4 of 10.
Aug 2022
30 Aug · Meeting
Jul 2022
Jun 2022
15 Jun · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
May 2022
30 May · Related Party Transaction
25 May · Results
11 May · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 30-Sep-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Apr 2022
Mar 2022
18 Mar · General updates
17 Mar · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Dec-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.8 Mar · General updates
Feb 2022
14 Feb · Results
14 Feb · Board meeting
5 Feb · Board meeting
1 Feb · Legal
Significant movement in price has been observed in Lotus Eye Hospital and Institute Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Dec 2021
31 Dec · Updates
28 Dec · Updates
Nov 2021
13 Nov · Results
13 Nov · Board meeting
Oct 2021
21 Oct · Board meeting
Sep 2021
6 Sep · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 30-Jun-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Aug 2021
30 Aug · Dividend
26 Aug · Corporate action
14 Aug · Results
14 Aug · Board meeting
4 Aug · Board meeting
Jul 2021
14 Jul · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted -2. Financial results not signed by authorized signatory/ies The response of the Company is awaited.
Jun 2021
30 Jun · Updates
30 Jun · Results
30 Jun · Board meeting